Financial Wire

歐洲、中東和非洲地區天然氣市場最新動態:受持續供應風險影響,期貨價格上漲

-- 週四盤後交易中,歐洲天然氣期貨價格延續漲勢,儘管有外交訊號可能緩和中東地緣政治緊張局勢,但價格仍堅挺。 荷蘭TTF近月合約上漲1.766%,至每兆瓦時42.13歐元(49.63美元);英國NBP期貨上漲1.785%,至每熱量單位105.52便士(1.43美元)。 Trading Economics表示,天然氣價格一度突破每兆瓦時42歐元,但仍接近六週多以來的最低水平,市場在權衡緩和局勢的初步進展與持續存在的供應風險。 新聞報導顯示,美國和伊朗正在進行間接談判,以延長目前為期兩週的停火協議(該協議將於4月22日到期),這可能會為與更廣泛的美以伊衝突相關的談判爭取更多時間。另據報道,黎巴嫩和以色列也在周四達成了停火協議。 然而,霍爾木茲海峽局勢仍不明朗。該海峽是全球能源流通的關鍵咽喉要道,約五分之一的液化天然氣運輸都要經過此地。目前,該水道交通嚴重受阻,美國封鎖了伊朗船隻,而德黑蘭方面則限制了大多數其他船隻的通行。 美國參謀長聯席會議主席丹凱恩將軍在周四的記者會上表示,美國的封鎖僅限於伊朗港口和海岸線,並不包括霍爾木茲海峽本身。他補充說,截至週四上午,美國中央司令部尚未在該地區登船檢查任何船隻,同時指出,美國印太司令部責任區內正在對封鎖實施前離開的船隻採取類似的海上攔截行動。 凱恩表示,已有13艘船掉頭,選擇不通過霍爾木茲海峽,高於本週稍早公佈的6艘。 Trading Economics報道稱,卡達拉斯拉凡液化天然氣(LNG)工廠是全球最大的LNG出口綜合體,即使重啟工作在5月啟動,預計也要到8月才能全面恢復運營,這加劇了供應方面的擔憂。 交易員們也在權衡和平前景的改善與冬季供暖需求下降和再生能源產量增強導致天然氣需求減少之間的關係。歐盟的天然氣庫存仍低於產能的30%,冬季前的補給工作已經開始。 同時,Investing.com引述荷蘭國際集團(ING)的數據報道稱,截至4月10日當週,投資基金將其在TTF的淨多頭頭寸減少了37太瓦時,至271太瓦時。 荷蘭國際集團分析師寫道:“顯然,中東地區的動盪持續的時間越長,來自亞洲的競爭就越激烈,因為買家會尋求替代供應。” 澳新銀行分析師丹尼爾·海恩斯(Daniel Hynes)在周四的報告中表示,儘管供應限制仍然是一個主要問題,但亞洲的LNG價格小幅走低。 亞洲液化天然氣進口量已降至2020年以來的最低水準。海恩斯補充說,截至4月14日,中國液化天然氣進口量的30天移動平均值為10.8萬噸,比去年同期下降32%。

Related Articles

Australia

Sector Update: Financial Stocks Softer Late Afternoon

Financial stocks fell in late Thursday afternoon trading with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.2%.The Philadelphia Housing Index dropped 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) rose 0.8%.Bitcoin (BTC-USD) gained 0.4% to $75,140, and the yield for 10-year US Treasuries advanced 2.7 basis points to 4.309%.In economic news, US initial jobless claims last week fell to 207,000 from a downwardly revised 218,000 in the previous week, compared with expectations for a smaller decrease to 213,000 in a survey of analysts by Bloomberg.US industrial production fell by 0.5% in March, compared with expectations for a 0.1% increase in a Bloomberg survey, and following an upwardly revised 0.7% increase in February.The Philadelphia Federal Reserve's monthly manufacturing index rose to 26.7 in April after increasing to 18.1 in March, compared with expectations for a decline to 10 in a survey compiled by Bloomberg.The New York Federal Reserve's services index improved to minus 14 in April from minus 22.6 in March, compared with minus 20 expected in a survey compiled by Bloomberg.In regulatory news, the US Securities and Exchange Commission is seeking public comment in support of a comprehensive review of the Consolidated Audit Trail and other such audit trails used in the regulation of the country's securities markets.In corporate news, Charles Schwab's (SCHW) Q1 results rose amid a surge in client assets, even as revenue fell short of Wall Street's estimates. The shares fell 7.7%.Goldman Sachs (GS) rates-trading business faced pressure in Q1 as Iran-related market volatility led to losses on certain positions, Reuters reported. The bank posted a 10% drop in fixed-income, currencies and commodities revenue to $4 billion, driven by weaker results in interest-rate trading, mortgages, and credit products, the report said. Goldman shares were little changed.Marsh & McLennan (MRSH) shares climbed 4.6% after the company reported Q1 adjusted net income and revenue that surpassed analysts' estimates.The National Basketball Association is in early discussions with private credit firms, including Apollo Global Management (APO), Ares Management (ARES) and Sixth Street about funding a potential European basketball league expansion, Bloomberg reported. Apollo shares rose 0.1%, and Ares fell 2.7%.

$APO$ARES$GS$MRSH$SCHW
Japan

US Equity Indexes Advance After Trump Announces Israel-Lebanon Ceasefire Deal

US equity indexes rose ahead of Thursday's close after Israel and Lebanon agreed to a 10-day ceasefire, removing a major obstacle to the Middle East diplomacy for a lasting Iran truce deal.The Nasdaq Composite rose 0.2% to 24,069.1, with the S&P 500 up 0.2% to 7,035.2, and the Dow Jones Industrial Average higher by 0.2% to 48,583.5. Energy, real estate, and technology led the gainers. Health care was the worst performer.President Trump said the US might hold discussions with Iran this weekend, The Wall Street Journal reported. "We're very close to making a deal," the president told reporters outside the White House, according to the WSJ. Trump said he wasn't sure the current two-week ceasefire in the war would need to be extended, according to the report.Earlier on Thursday, Trump said on Truth Social that Lebanon and Israel have agreed to a 10-day ceasefire starting 5 pm ET. Lebanese Prime Minister Nawaf Salam said he welcomed the decision. In a follow-up social media post on Thursday, Trump said he will invite the Lebanese President, Joseph Aoun, and Israel's Prime Minister Benjamin Netanyahu to the White House for talks.Meanwhile, US Defense Secretary Pete Hegseth said Thursday that the naval blockade of Iran is an example of "polite" behavior during the ongoing ceasefire, and US forces are ready to strike power plants and the energy industry in the country, if ordered, according to a report from Reuters.West Texas Intermediate crude oil futures rose 2.5% to $93.77, and Brent crude futures jumped 3.7% to $98.58.

$^DJI$^IXIC$^SPX
Sectors

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were softer late Thursday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.7%.The iShares Biotechnology ETF (IBB) dropped 1.3%.In corporate news, Abbott Laboratories (ABT) lowered its full-year earnings outlook on Thursday to reflect the acquisition of cancer diagnostics company Exact Sciences, while the healthcare firm reported Q1 results above market estimates. Its shares fell past 5%.Gilead Sciences (GILD) could beat Q1 consensus estimates, but weaker-than-expected persistence rates for Yeztugo point to a potential risk to long-term peak sales for the HIV pre-exposure prophylaxis drug, RBC Capital Markets said in a note. Gilead shares were down 0.8%.QuidelOrtho (QDEL) shares tumbled 28%. The company said late Wednesday it expects preliminary unaudited revenue of $615 million to $620 million for Q1. Analysts polled by FactSet expect $677.8 million.Hims & Hers Health (HIMS) shares jumped past 12% after a senior US health official signaled plans to ease restrictions on certain peptides.

$ABT$GILD$HIMS$QDEL